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A “dock, lock, and latch” Structural Model
for a Staphylococcal Adhesin Binding to Fibrinogen
the first critical step in the establishment of most bacte-
rial infections. This process involves adhesins on the
surface of the microbe that bind to ligands in the host
Karthe Ponnuraj,1 M. Gabriela Bowden,2
Stacey Davis,2 S. Gurusiddappa,2
Dwight Moore,1 Damon Choe,2
in “lock and key” interactions. For pathogenic bacteriaYi Xu,2 Magnus Hook,2,*
that do not invade host cells, extracellular matrix pro-and Sthanam V. L. Narayana1,*
teins are preferred targets for bacterial adhesion. On1School of Optometry and Center for Biophysical
gram-positive bacteria such as Staphylococci, Strepto-Sciences and Engineering
cocci, and Enterococci, the adhesins mediating theseUniversity of Alabama at Birmingham
interactions have been termed MSCRAMMs (microbialBirmingham, Alabama 35294
surface components recognizing adhesive matrix mole-2 Center for Extracellular Matrix Biology
cules) (Patti and Hook, 1994). Multiple MSCRAMMs haveInstitute of Biosciences and Technology
been found in many pathogenic gram-positive species,Texas A&M University Health Science Center
and their amino acid sequence relatedness, similar mod-Houston, Texas 77030
ular design, and common binding domain organization
suggest that they might have arisen from a common
ancestor. In general, these structurally related MSCRAMMsSummary
contain an N-terminal 40 amino acid long signal se-
quence (S), and C-terminal features that are requiredGram-positive pathogens such as staphylococci con-
for sorting the proteins to the cell wall including a pro-tain multiple cell wall-anchored proteins that serve as
line-rich wall-spanning region (W), the wall anchoringan interface between the microbe and its environment.
LPXTG motif, a hydrophobic transmembrane region (M),Some of these proteins act as adhesins and mediate
and a positively charged cytoplasmic tail (C). In additionbacterial attachment to host tissues. SdrG is a cell
to these C-terminal features, the members of the Sdrwall-anchored adhesin from Staphylococcus epider-
family of proteins, including the fibrinogen (Fg) bindingmidis that binds to the B chain of human fibrinogen
MSCRAMMs ClfA and ClfB of S. aureus, and SdrG of(Fg) and is necessary and sufficient for bacterial at-
S. epidermidis contain a Ser-Asp repeat region (R re-tachment to Fg-coated biomaterials. Here, we present
gion) just outside the cell wall-anchoring region (see thethe crystal structures of the ligand binding region of
SdrG prototype in Figure 1A). The ligand binding activitySdrG as an apoprotein and in complex with a synthetic
of most of these MSCRAMMs has been localized to thepeptide analogous to its binding site in Fg. Analysis
N-terminal A regions that are 500 amino acid longof the crystal structures, along with mutational studies
(reviewed by Foster and Hook, 1998). In the case ofof both the protein and of the peptide, reveals that
SdrG, the ligand binding site has been further localizedSdrG binds to its ligand with a dynamic “dock, lock,
to residues 273–597 (Davis et al., 2001).and latch” mechanism. We propose that this mecha-
Fg appears to be targeted by many pathogens, andnism represents a general mode of ligand binding for
staphylococci can express several different proteinsstructurally related cell wall-anchored proteins of
that bind to this host component. For instance, the S.gram-positive bacteria.
aureus MSCRAMMs ClfA, ClfB, FnbpA, and FnbpB all
recognize Fg. In addition, this organism can secreteIntroduction
several Fg binding proteins including Map/Eap (Jo¨nsson
et al., 1995, Palma et al., 1999), Efb (Palma et al., 2001),
Staphylococcus epidermidis is a major component of
and Emp (Hussain et al., 2001). During tissue repair, Fg
the normal skin flora, colonizing the healthy human epi-
not only controls blood loss by clotting, but it is also
dermis and mucous membranes. However, S. epider- part of the host defense against microbial infections.
midis has evolved into one of the leading causes of In damaged tissues, the proteolysis of Fg by thrombin
nosocomial sepsis; this opportunistic pathogen is now releases potent chemotactic fragments such as fibrino-
the most common organism isolated from nosocomial peptide B, attracting leucocytes and fibroblasts to the
primary blood stream infections (BSI) (Richards et al., site of injury (Kay et al., 1974; Richardson et al., 1976;
2000). Alarmingly, antibiotic resistance is emerging Senior et al., 1986; Skogen et al., 1988). We have shown
among S. epidermidis strains and other related gram- previously that SdrG’s binding site in the Fg B chain
positive opportunistic pathogens such as S. aureus and overlaps the thrombin cleavage site and that SdrG can
E. faecalis. The emergence of these multiple antibiotic- interfere with fibrin clot formation by inhibiting the
resistant strains constitutes an imminent public health thrombin mediated release of fibrinopeptide B (Davis
crisis. Therefore, we need a better understanding of et al., 2001). It is possible that staphylococci express
the pathogenic molecular strategies employed by these proteins that bind to Fg to prevent the release of chemo-
organisms to develop new antimicrobial drugs and treat- tactic elements, thus reducing the influx of phagocytic
ments. neutrophils to the infection site and enhancing the bac-
Microbial attachment to the host tissues represents terial survival in the host.
In this report, we present the crystal structure of the
Fg binding domain of SdrG, both as an apoprotein and*Correspondence: narayana@uab.edu (S.V.L.N.), mhook@ibt.tamu.
edu (M.H.) in complex with a synthetic peptide analogous to the
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Figure 1. Representation of the rSdrG(276–597)-Peptide Complex
(A) Schematic representation of the SdrG molecule (Top): A, N-terminal Fg binding region; N2-N3, subdomains crystallized in the rSdrG(276–597)-
peptide complex; B1 and B2, repeats of unknown function; R, serine-aspartate repeat region; W, wall-spanning region; M, membrane-spanning
region; C, cytoplasmic positively charged tail. The amino acid residue number identifying the boundary between each subdomain is indicated
below. The Fg (6-20) peptide sequence (Below). The arrow indicates the thrombin cleavage site.
(B) Stereo ribbon (Carson, 1997) representation of rSdrG(276–597)-Fg (6-20) peptide analog complex. The peptide is shown in the “ball and
stick” model.
(C) Schematic representation of the topology of the rSdrG(276–597) fold. The N2 and N3 domains are shown in green and yellow, respectively.
The dotted line at the end of the G strand indicates the C terminus of the apo-rSdrG(276–597) structure. In the rSdrG(276–597)-peptide complex, the
C-terminal strand inserts between strands D and E of the N2 domain.
binding site in its ligand, human Fg. Using a combination would generate a recombinant fusion protein covering
residues 273–597 of SdrG with an N-terminal His-tag forof site-directed mutagenesis in SdrG(273–597) and amino
acid replacements in the Fg (6-20) peptide, we have purification purposes. This recombinant SdrG(273–597) was
crystallized in complex with its ligand, a synthetic pep-developed and examined a model for the mechanism
of the MSCRAMM-ligand interaction. In addition, our tide designed to contain residues 6–20 of the human Fg
-chain (Figure 1A). The structure of the rSdrG(276–596)-analyses suggest that this mechanism is a common
mode of ligand binding among structurally related peptide complex was determined by multiple isomor-
phic replacement methods. The solvent flattened elec-MSCRAMMs from gram-positive bacteria.
tron density map was readily interpretable and allowed
a model for the structure of the rSdrG(276–596)-peptideResults and Discussion
complex to be built. The structure has been refined to
an R factor of 20.9% (Rfree of 22.1%) against diffractionStructure of the SdrG(276–596)-Fg Peptide Complex
Initial characterization of the recombinant A-region of data extending to 1.86 A˚ resolution (Table 1). There are
two independent molecules in the crystallographicSdrG revealed that this protein is readily processed at
the N terminus by a contaminating protease, yielding a asymmetric unit of a P2I2I2I cell and they exhibit an
identical structure with an rms deviation of 0.2 A˚ on allresistant fragment corresponding to residues 273–597
(Figure 1A). Similar processing was previously observed C atoms upon superposition.
The folding of the rSdrG(276–597) molecule with a boundin vivo for the A-region of ClfB (McAleese et al., 2001)
and in vitro for the A-region of ClfA (Deivanayagam et peptide is illustrated in Figure 1B. No electron density
was observed for the 20 N-terminal residues, which in-al., 1999). We therefore reengineered a plasmid that
Crystal Structure of MSCRAMM-Ligand Complex
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“sandwich” and strands D1, D2, C, F, and G on theTable 1. Peptide Bound and Free rSdrG(276–597) Crystallographic
and Refinement Data opposite face (Figure 1C). The insertion of the additional
strands D1 and D2 represent the unique feature of theParameter Peptide Bound Peptide Free
DEv-IgG fold compared to the C-type IgG fold. In the
a (A˚) 89.02 44.39 N2 domain, strands D1, D2, C, F, and G form one sheet,
b (A˚) 89.48 92.76
the second sheet contains an additional strand G″ in-c (A˚) 98.04 93.92
serted between the E and the D. This inserted G″ strand () 90 83.62
is not formed by residues from the N2 domain, but in- () 90 76.06
 () 90 90.57 stead, it is formed by residues Ser587-Glu597 that repre-
Space group P212121 P1 sent the C-terminal extension of the N3 domain (Figure
Resolution (A˚) 1.86 3.5 1C). The inserted G″ strand buries a surface area of
Reflections total/unique 549,956/63,746 57,863/13,739
1138 A˚2 of the N2 domain.Completeness (%) 95.7 97.3
Rsyma 6.1 8.4
Structural Features of the SdrG Binding SiteNumber of molecules in the 2 4
asymmetric unit A cleft of approximately 30 A˚ in length between the N2
and N3 domains constitutes the Fg binding region ofRefinement
rSdrG(276–596). The Fg-derived peptide fits snuggly into this
Resolution range (A˚) 20–1.86 20.0–3.5 cleft in an extended conformation, interacting with both
R factor/Rfreeb 0.209/0.221 0.250/0.319
the N2 and the N3 domains (Figure 1B). A well-defined(All data with 0 sigma cutoff)
electron density was observed for most of the residuesAverage B value (A˚2) 20.53 30.34
Rmsd for bonds (A˚) 0.006 0.012 of the bound peptide (Figure 2A) except for three
Rmsd for angles () 1.27 1.51 N-terminal (Asn6f, Glu7f and Glu8f) and two C-terminal
Number of nonhydrogen 5003 8216 residues (Leu19f and Asp20f). These residues are ex-
protein atoms tended into the solvent environment, having few interac-
Number of peptide atoms 170
tions with the SdrG molecule, and with a weak electronNumber of water molecules 438
density in the 2fo-fc maps. The superposition of theNumber of Ca2 ions 2
PDB code 1R17 1R19 bound peptide in the two complex structures shows an
rms deviation of 0.16 A˚ (on main chain atoms) indicatinga Rsym|Ih	
Ih|/Ih, where 
Ih is the average intensity over
that the conformations of the peptide in both structuressymmetry equivalents.
are nearly identical.b Number of reflections set aside for calculation of the Rfree value for
peptide bound and unbound structures were 1239 and 669, respec- The central region of the cleft is covered by residues
tively. Ile581-Ser586, a segment corresponding to the linker
connecting the N3 domain G strand with strand G″
strand of the N2 domain, giving the binding region
a “tunnel-like” appearance (Figure 2B). The peptideclude 12 residues contributed by the vector His6-tag
residues Phe9af-Ala13f are positioned in this tunnel,sequence and residues 273–275 of the rSdrG protein.
appearing as if the peptide is threaded through theLikewise, no electron density was observed for one resi-
rSdrG(276–596) molecule.due (two residues in the second molecule of the asym-
An area of 1200 A˚2 is buried between rSdrG(276–596) andmetric unit) of the rSdrG C terminus. The rSdrG(276–596)
the peptide, involving 62 contacts with less than 4 A˚polypeptide folds into two distinct domains; N2 and N3.
between the protein and the peptide ligand. For exam-In agreement with earlier terminology (Perkins et al.,
ple, there are 8 antiparallel backbone hydrogen bonds2001), the term N1 has been reserved for the proteolyti-
between residues Phe10f, Ser12f, Arg14f, and His16f incally processed N-terminal segment of the A-region. The
the peptide and Ser584, Ala582, Thr580, and Asp578 intopologies of N2 and N3, with 13% residues conserved
the “linker” and the N3 domain of rSdrG(276–596) (Figurebetween them are structurally similar and follow the
2C). In addition, the peptide residues Gly15f, Ala13f, andDEv-IgG (DEvariant-IgG) fold (Figure 1C). The DEv-IgG
Phe11f form four more backbone-backbone hydrogenfold, which represents a variant of the C-type immuno-
bonds with residues His304, Ala306, and Leu340 of theglobulin fold, was recently identified in the crystal struc-
N2 domain. The backbone atom of Phe11f makes ature of the apo-rClfA(221–559), the minimum Fg binding re-
hydrogen bond with the side-chain of Ser338. The sidegion of the MSCRAMM clumping factor A (ClfA) from
chains of the peptide amino acids form two hydrogenS. aureus (Deivanayagam et al., 2002). The N2 and N3
bonds with rSdrG(276–596): (1) Arg14f (NH1) to Tyr294 (OH)domains in the rSdrG(276–596)-peptide crystal structure in-
and (2) Ser12f (OG) to Asp339 (OD2). Three Phe residuesteract with each other and have a combined buried sur-
(Phe9af, Phe10f, and Phe11f) in the N terminus exhibit aface area of 1378 A˚2. The N-terminal N2-domain has 148
large number of hydrophobic interactions with residuesresidues (276–424), and is slightly smaller than the N3
from the N2 and the N3 domains and appear like a “bulgydomain, which has 170 residues (425–597). The N2 and
plug” positioned at the end of the tunnel of the ligandN3 domains superpose with an rms deviation of 1.8 A˚
binding cleft.for 48 common C atoms and 3.7 A˚ on all C atoms,
and the differences are mostly found in the length and
conformation of the loops joining the  strands of the SdrG-Ligand Binding Specificity
Based on the rSdrG(276–596)-peptide complex structure wetwo domains.
The two principal  sheets of the N3 domain are com- predicted which amino acids in rSdrG(276–596) and in the
peptide are important to stabilize the adhesin-ligandposed of  strands A, B, E, and D on one face of a
Cell
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Figure 2. rSdrG(276–597)-Peptide Interactions
(A) 2Fo-Fc simulated annealing omit map of the Fg (6-20) peptide analog. The map is contoured at the level of 1. The peptide residues are
distinguished from the protein residues by the suffix “f”.
(B) Surface representation of rSdrG(276–597) showing the peptide “locked” into the molecule. The surface is color-coded according to nonpolar,
polar, acidic, and basic residues that are represented as green, white, red, and blue, respectively. Closer view of the ligand binding tunnel is
shown in ribbon representation.
Crystal Structure of MSCRAMM-Ligand Complex
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Figure 3. Mutational Analysis of rSdrG(273–597) and 6-20 Peptide
(A) Surface plasmon resonance (SPR) was used to analyze the interaction of wild-type and mutated versions of rSdrG(273–597) with the 1-25
peptide immobilized on a BIAcore sensor chip. Lines represent: ( ), SdrG(273	–597); (—–), SdrG(273–597)D339A; (·······), SdrG(273–597)S338H.
(B) Mutation of peptide 6-20 by amino acid replacement. Ala or Ser (A or S) was used to replace each residue within Fg (6-20) in a panel
of synthetic peptides. The Ala or Ser replacement residues are shown in bold.
(C) Mutant peptide inhibition of rSdrG(273–597) binding to Fg. 50 nM rSdrG(273–597) was preincubated with the different synthetic peptides (10 nM)
for 1 hr at RT and then transferred to microtiter wells coated with 1 g human Fg. After incubation for 1 hr at RT, bound SdrG was detected
as described in the Experimental Procedures section. Peptides with residue replacements that affected inhibition (7-12) are shown in dark bars.
(D) The rSdrG(273–597) C terminus is essential for binding to Fg-derived peptides. Surface plasmon resonance shows the binding of rSdrG(273–597)
(·· ··), rSdrG(273–589) ( ) and rSdrG(273–580) (- - -) to the 1-25 peptide immobilized on a BIAcore sensor chip.
complex. To test these predictions, we constructed two not shown), with identical results. Both mutations com-
pletely abolished the ability of rSdrG(273–596) to bind topoint mutants by site-directed mutagenesis replacing
residues Ser338 and Asp339, that interact with Phe11f human Fg.
A closer inspection of the rSdrG(276–596)-peptide com-and Ser12f of the peptide (Figure 2D), with His and Ala
respectively. We predicted that, the S338H and D339A plex suggests that the specificity of the peptide for
rSdrG(276–596) is determined by the residues Phe10f,mutations would not only disturb the protein-peptide
hydrogen bonds, but also that the S338H mutation Phe11f, Ser12f, Ala13f, Arg14f, and Gly15f (Figure 2D).
To further examine which residues within the Fg -chainwould introduce a larger side chain within the binding
region, occupying the space where the peptide docks, sequence (6-20) are necessary for peptide binding to
rSdrG(273–597), we synthesized a panel of mutant peptidesthus preventing ligand binding. We tested the ability of
the rSdrG(273–596)S338H and rSdrG(273–596)D339A to bind to (Figure 3B) replacing each residue in the native Fg
-chain sequence with an Ala (or Ser if Ala is presentthe immobilized 1-25 peptide in the BIAcore (Figure
3A) and to immobilized Fg in an ELISA-type assay (data in the native sequence). The ability of the synthesized
(C) Schematic representation of rSdrG(276–597)-peptide interactions. The  strands are colored purple and yellow for the peptide and the rSdrG
molecule, respectively. Hydrogen bonds are indicated by dotted lines.




significantly contribute to the binding to SdrG (Figure
3C). The peptide residues identified by this method coin-
cides with those shown to contact rSdrG(276–597) in the
cocrystal structure. Interestingly, these residues include
Arg14f and Gly15f, the thrombin cleavage site of the
FgB chain.
The crystal structure presented in Figure 1B was ex-
pected to show the complex of rSdrG(276–596) with its li-
gand, a peptide corresponding to residues 6–20 of the
human Fg -chain (Figure 2A). However, in the crystal
structure solved, the bound peptide contains an addi-
tional Phe residue in between position 9 (Gly9f) and 10
(Phe10f) (Figure 2A) that is not present in the human Fg
sequence. Therefore, the peptide present in the cocrys-
tal is an analog of 6-20 containing three consecutive
Phe residues [6-20(F3)] instead of two. This additional
Phe residue (Phe9f), along with the two Phe residues
present in the native sequence (Phe10f and Phe11f),
contributes to the hydrophobic stacking interactions
with rSdrG(276–596). It is likely that the 6-20 peptide prepa-
ration utilized in the cocrystal complex formation con-
tained a contaminating peptide with an additional Phe
residue. Since this was the “selected” peptide in the
crystallization process, the contaminating peptide is
predicted to have a higher affinity for SdrG compared
to a peptide representing the native sequence. We there-
fore synthesized the 6-20 and 6-20(F3) peptides, puri-
fied them, and examined their binding to rSdrG(273–597) by
fluorescence polarization (FP) spectroscopy, isothermal
titration calorimetry (ITC) and surface plasmon reso-
nance (SPR) (Figures 4A, 4B, and 4C). The results of the
FP and ITC experiments indicate that rSdrG(273–597) binds
more tightly to the 6-20(F3) peptide compared to the
6-20 peptide, reflected by an almost 8-fold lower KD.
Amino acid modeling at positions Ser12f, Ala13f andFigure 4. The 6-20 Peptide Is Not the Optimal SdrG (273-597) Ligand
Gly15f suggests that larger side-chain residues would(A) Binding of rSdrG(273–597) to fluorescein-labeled synthetic peptides
quantitated by fluorescence polarization. Increasing concentrations not be accommodated at these locations. Closer exami-
of rSdrG(273–597) were incubated with synthetic fluorescein-labeled nation of the binding pockets of these residues revealed
wild-type and mutant peptides (10 nM). The calculated KD for each that the replacement of Gly15f with Ser would provide
interaction was: rSdrG-(6-20) [], 379 nM; rSdrG-(6-20G15S) [],
additional hydrogen bonds with Gln425, Gln579, and302 nM; rSdrG-[6-20(F3)] [], 49 nM.
Ser437 in rSdrG(276–596) (Figure 2D). Thus, this variant pep-(B) Binding of SdrG(273–597) to unlabeled synthetic peptides quantitated
tide is predicted to have a higher affinity for SdrG com-by isothermal titration calorimetry. A 20 M solution of SdrG(273–597)
was incubated with an increasing concentration of synthetic pep- pared to a peptide based on the wild-type Fg sequence.
tides. The calculated KD for each interaction was: rSdrG-(6-20) As expected, the G15fS mutation resulted in a peptide
[], 380 nM; rSdrG-(6-20G15S) [], 300 nM; rSdrG-[6-20(F3)] [], that exhibited increased binding affinities when com-
50 nM.
pared to the native 6-20 peptide, both in the FP and(C) Representative profiles of the relative SPR responses for the
the ITC assays (Figure 4B). Taken together, these resultsbinding of synthetic peptides to rSdrG(273–597) immobilized on a BIA-
demonstrate that the human Fg residues bound by SdrGcore sensor chip. Colors represent: (Red), 6-20(F3); (Green), 6-
20(G15S); (Blue), 6-20; (Cyan), 6-20(F11A); (Pink), 1-25 do not represent the amino acid sequence of the optimal
(scrambled). ligand. Similarly, in the case of the S. aureus ClfA, we
have found synthetic peptide analogs representing
amino acid variants of its known ligand, the C terminusmutant peptides to bind to rSdrG(273–597) was tested in an
of the Fg -chain that show higher affinity for theinhibition assay. Peptides number 7, 8, 9, 10, 11, and
MSCRAMM than the native Fg sequence (M.H., unpub-12 were the least effective in inhibiting the binding of
lished data). Thus, structurally related MSCRAMMs con-rSdrG(273–597) to immobilized human Fg, indicating that
taining repeated immunoglobulin-like folds such asthese peptides have a lower affinity for SdrG than the
SdrG and ClfA can accommodate linear peptides withunmodified peptide. Using surface plasmon resonance
a certain degree of ligand sequence variability.we confirmed that peptide number 8 (F11A) binds less
well to immobilized Fg compared to the native 6-20
peptide and only slightly better than a 1-25 scrambled SdrG Inhibits the Thrombin Cleavage of the Fg
B-Chain: a Structural Analysissequence peptide (Figure 4C). These data indicate that
the amino acids Phe10f, Phe11f, Ser12f, Ala13f, Arg14f During blood clotting, thrombin cleaves the two A
chains of Fg rapidly at Arg16f and the two B-chains atand Gly15f, which are replaced in peptides number 7-12,
Crystal Structure of MSCRAMM-Ligand Complex
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Arg14f more slowly to release fibrinopeptides A and is empty, leaving the binding cleft between the N2 and
N3 domains widely open and presumably providing easyB, respectively. Although the structure of the complex
thrombin-fibrinopeptide B has not been reported, the access for the ligand to dock within the binding cleft.
The disordered regions in all four molecules of apo-existing structural (Malkowski et al., 1997; Martin et al.,
1992, 1996), biochemical and mutational (Le Bonniec et rSdrG(276–596) in the asymmetric unit are better defined
in the rSdrG(276–596)–peptide complex. For example, theal., 1991) data on complexes of thrombin-fibrinopeptide
A and its analogs (Blomback, 1986; Scheraga, 1986; region encompassing amino acids Lys350-Glu355 that
is disordered in the apo structure forms the D strand inLord et al., 1990; Binnie and Lord, 1993) show that the
N-terminal A chain of Fg interacts with thrombin the complex structure, interacting with strand G″ of the
N2 domain through hydrogen bonds. Similarly, Phe373-through its residues P10-P4 (8-20). In the present
rSdrG(276–597)-peptide complex structure, residues P7-P4 Glu381 region is stabilized by the hydrogen bonds
formed with the N2 domain G″ strand. In addition, the(9-18) of the peptide interact with rSdrG(276–597). Thus,
we can now provide the structural explanation for the residue Tyr552 of the connecting loop (Tyr545-Tyr552)
between E and F strands makes key van der Waalspreviously reported (Davis et al., 2001) SdrG interference
with thrombin-mediated release of fibrinopeptide B, as contacts by stacking against Phe9af and Phe11f resi-
dues of the peptide. The structural rearrangements andthe SdrG binding site overlaps with the thrombin cleav-
age site in the Fg B chain. the direct protein-ligand interactions formed upon pep-
tide binding result in an effectively stabilized rSdrG(276–596)In addition, the rSdrG(276–597)-peptide complex structure
provides an explanation for why SdrG can bind the Fg complex compared to its apoform.
B chain but not the structurally related A chain. In
the N-terminal A(7-20) (DFLAEGGGVRGPRV-thrombin A Dynamic Model for Ligand Binding
cleavage site shown in bold) the P2, P1 and P1positions The structural comparison of apo-rSdrG(276–596) and the
are occupied by residues Val, Arg, and Gly, compared rSdrG(276–596)-peptide complex provides the basis for a
to Ala, Arg, and Gly in the Fg B chain. These sets of ligand binding model. The open conformation of the
residues are very similar and both easily would fit in the rSdrG(276–596) apoprotein (Figure 5C) contrasts with the
respective pockets of SdrG. However, the P5, P4, and closed conformation (Figure 5B) observed for rSdrG(276–596)
P3 positions are occupied by Gly, Gly, Gly in the A in the protein-ligand complex. In the protein-ligand com-
chain and Phe, Phe, and Ser residues in the B chain, plex, the C-terminal segment of the protein, which is an
respectively. These substitutions would result in the extension of the N3 domain, “locks” on to the “docked”
elimination of a critical hydrogen bond [Ser12f (OG) with peptide by forming a cover and sequesters it by
Asp339 (OD2)] and the hydrophobic interactions that “latching” on to the neighboring N2 domain. Thus, pep-
Phe10f and Phe11f make with rSdrG(276–596), giving the tide binding to rSdrG(276–596) appears to involve multiple
A chain a much lower binding affinity for rSdrG(276–596) steps: initially, the peptide docks in the cleft. This bind-
compared to that of the B chain. ing event is followed by a structural rearrangement at
the rSdrG(276–596) C terminus that begins with a deviation
in the strand direction at Ile581. Because of this devia-Structure of the apo-rSdrG(276–597) Protein
tion, the strand crosses over the binding cleft and locksThe structure of the apo-rSdrG(273–596) was solved by mo-
the peptide in place. This crossover results in the forma-lecular replacement methods using the structure of the
tion of backbone hydrogen bonds between the boundrSdrG(276–596) component of the peptide-MSCRAMM com-
peptide and the covering segment (Ile581-Ser586) of theplex as a starting model. The apo-rSdrG(276–596) structure
adhesin, securing the peptide in the binding pocket. Thewas solved at a 3.5 A˚ resolution, with four molecules in
final step is the complementation of a  sheet in the N2an asymmetric unit of a P1 cell. Structurally, the four
domain, inserting the C-terminal strand (G″) betweencopies are very similar, but each molecule shows several
strands E and D. This last latching event stabilizes theshort disordered segments. As a result, the molecular
overall structure.model structures were truncated in up to six places. A
high degree of disorder was also observed at the C
terminus, where 12 to 14 of the terminal residues could Truncation Mutants Support the Binding Model
To examine the proposed dock, lock, and latch model ofnot be modeled.
To compare the structures of rSdrG(276–596) as an apo- ligand binding, we constructed two truncation mutants:
rSdrG(273–589) contains a midablated version of the N2 G″protein and in complex with the peptide, we chose the
apoprotein structure that showed the best resolved C C terminus  strand, and rSdrG(273–580) is completely de-
void of the N2 G″C terminus  strand and the connectingterminus out of four molecules available in the P1 cell.
A structural comparison of rSdrG(276–596) as an apoprotein residues between the N2 G″ and the N3 G strand. We
hypothesized that, given the importance of these C-ter-and in complex with the peptide (Figure 5A) shows an
rms deviation of 1.1 A˚ for 276 C atoms and revealed minal residues in ligand binding and structure stabiliza-
tion, the rSdrG(273–589) polypeptide would show a de-that the major difference between the two forms is at
their C termini. In the rSdrG(276–596) peptide-complex creased ability to bind to Fg, and that rSdrG(273–580) would
be completely unable to bind to Fg. Our results showstructure, the C-terminal region forms a regular  strand
(G″) that is inserted between strands E and D of the that, as predicted, the rSdrG(273–589) polypeptide has a
markedly reduced affinity for the ligand, and that bindingN2 domain (Figure 5B). In the apo-rSdrG(276–596) structure
(Figure 5C), the C terminus does not interact with the of rSdrG(273-580) to the peptide is nearly null when com-
pared to the binding level of the intact rSdrG(273–597) (FigureN2 domain, it extends into the solvent region. Therefore,
the space between the D and E strands in the N2 domain 3D). These data strongly suggest that our predicted
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Figure 5. Backbone Representation and Comparison of the apo-rSdrG(273–597), rSdrG(273–597)-Peptide Complex and apo-rClfA(221–559) Structures
(A) The superposition of C backbones of rSdrG(273–597)-peptide (light green) with the apo-rSdrG(273–597) structure (gold).
(B) Representation of the “closed” rSdrG(273–597)-peptide complex (light green and purple respectively) and (C) the “open” apo-rSdrG(273–597) confor-
mation.
(D) The apo structure of rClfA(221–559) (light brown). The C terminus of rClfA(221–559) (green) loops back and folds into the N3 domain, partially
blocking the proposed ligand binding cleft. The conserved TYTFTDYVD motif is highlighted in gray (B and D).
multistep model of ligand binding and strand comple- that it is involved in the structural preservation of the
latching cleft.mentation is correct.
To investigate how widespread the dock, lock, and
latch model might be among bacterial cell wall proteins,A Family of Structurally Related, Cell Wall-Anchored
we searched for MSCRAMM candidates in the genomicProteins from Gram-Positive Bacteria
sequences from five gram-positive pathogens. In theWe have recently solved the structures of the ligand bind-
analyzed genomic sequences, the number of predicteding domains of the S. aureus Fg binding MSCRAMMs;
cell wall anchored proteins varied from 8 (S. mutants) torClfA(221–559) (Figure 5D) (Deivanayagam et al., 2002) and
41 (E. faecalis) (Table 2). Computer-generated structuralrClfB(200–554) (Champion Deivanayagam, Samuel Perkins,
models suggest that IgG-like subdomains arranged inEvelyn Walsh, Timothy Foster, M.H., and S.V.L.N., un-
tandem are present in 22%–45% of the predicted cellpublished data). Although these adhesins bind to differ-
wall anchored proteins. Furthermore, all of the S. aureusent chains in Fg, the overall domain arrangement and
proteins containing repeated IgG-like subdomains havethe topology of the individual domains are strikingly
a TYTFTDYVD-like sequence in one of the repeats. Thesesimilar. The structural data for rClfA(221–559) and rClfB(200–554)
include the Fg binding domains found in ClfA, ClfB,are available only for the apoprotein. However, both
FnbpA, and FnbpB, the collagen binding MSCRAMMsapoproteins contain a putative ligand binding cleft be-
Cna, the bone sialoprotein binding protein Bbp and thetween the N2 and N3 domains and an empty latching
SdrC-E proteins, for which ligands so far have not beencleft between the D and E strands of the N2 domain
identified. A TYTFTDYVD-like motif is also present inthat could accommodate a complementing “guest”
SdrG and SdrF from S. epidermidis, and in the firststrand. In fact, in the rClfB(200–554) crystal structure, this
N-terminal IgG-like subdomain of two E. faecalis cellspace is occupied by the C-terminal end of a neigh-
wall anchored proteins, including the collagen bindingboring crystallographically related molecule that forms
MSCRAMM Ace (Jouko Sillanpaa, Y.X., Sreedhar Nalla-a G″ like strand and occupies the cleft between the
pareddy, Barbara Murray, and M.H., unpublished data).E and D strands of the N2 domain (data not shown).
A recent crystal structure determination of the Ace colla-Interestingly, the previously identified conserved se-
gen binding domain suggests that this motif forms thequence motif TYTFTDYVD (McCrea et al., 2000) consti-
base of a cleft into which a hypothetical latching strandtutes the back of the latching cleft in rSdrG(273–597) (strand
could insert (K.P, Y.X., D.C., M.H., and S.V.L.N., unpub-D2 and a short -helix connecting it to the E strand in
lished data). Remnants of this motif are also found inthe N2 domain shown in gray color in Figure 5B). This
several streptococcal proteins. The structures of theseconserved motif is found in a similar location in the
proteins have not yet been solved, and we do not knowrClfA(221–559) and rClfB(200–554) crystal structures. At the mo-
if the identified remnants of the TYTFTDYVD motif signifyment, we do not understand the precise function of this
conserved sequence, but it is tempting to speculate a latching cleft in one of the predicted  sheets.
Crystal Structure of MSCRAMM-Ligand Complex
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Table 2. Summary of Predicted LPXTG-Motif Cell Wall-Anchored Proteins of Gram-Positive Organisms with Repeated
Immunoglobulin-Like Fold
Number of Predicted
LPXTG-Motif Cell Wall Number with Predicted
Organism Anchored Proteins Repeated Ig-Like Fold
Enterococcus faecalis 41 9
Staphylococcus aureus 22 9
Staphylococcus epidermidis 11 5
Streptococcus mutans 8 3
Streptococcus pneumoniae 19 6
Additional details and methods used to generate this table are available as Supplemental Data (See Supplemental Table S2 available at
http://www.cell.com/cgi/content/full/115/2/217/DC1).
Another structural feature conserved in the analyzed suggest that the dock, lock, and latch mechanism is
likely to represent a general mode of ligand capture byproteins is an amino acid pattern in their C-terminal
latching strand sequences. Structural analysis of the the A-domains of structurally related cell wall-anchored
adhesins of gram-positive bacteria.SdrG latching sequence [SSGQGQG (586–592)] reveals
that it is formed by alternating small residues (Ser586, The salient features of the dock, lock, and latch model
include a ligand binding-induced redirection of theGly588, Gly590, and Gly592) with their short side chains
facing the larger side chains (Tyr and Phe) of the TYTFT C-terminal end of the N3 domain of SdrG, followed by
an insertion of this redirected C-terminal extension be-DYVD motif present in the opposite  sheet. The crystal
structures of apo-rClfB (Champion Deivanayagam, tween strands E and D in the preceding N2 domain. This
molecular rearrangement represents an intramolecularSamuel Perkins, Evelyn Walsh, Timothy Foster, M.H.,
and S.V.L.N., unpublished data) and the collagen bind-  sheet complementation that is, to our knowledge,
unique.ing MSCRAMMs Ace (K.P., Y.X., D.C., M.H., and
S.V.L.N., unpublished data) and Cna (Yinong Zong, Y.X., Intermolecular  strand complementation is not an
unusual mechanism of protein-protein interaction. InM.H., and S.V.L.N., unpublished data) show that their
latching sequences also exhibit a pattern of alternating this case, a strand from one protein complements a 
sheet in the interacting protein. An example of this typesmall residues. Modeling the C terminus of the apo-
rClfA structure (Figure 5D) into the latching cleft of its of protein-protein association is the interaction of the
PapD-like chaperons with pilus subunits during pili as-N2 domain reveals a “GSGSGDG” motif that could oc-
cupy the latching cleft, following the pattern found in sembly in E. coli (Sauer et al. 1999; Choudhury et al.,
1999). Recently, the ligand binding mechanism for fibro-SdrG and other MSCRAMM structures. In addition, we
identified potential latching sequences in putative nectin binding MSCRAMMs from gram-positive bacteria
was elucidated (Schwarz-Linek et al., 2003). In this case,MSCRAMM proteins from Staphylococci and Entero-
cocci using homology modeling and sequence align- an unordered repeated motif of the MSCRAMM interacts
with the set of type I modules of the N-terminal domain ofment methods and found that these sequences also
follow a pattern of alternating small residues (Table 3). fibronectin through a multiple strand complementation
event called a -zipper mechanism. This intermolecularThis observation, together with the conservation of a
TYTFTDYVD-like motif in the back of the latching cleft  strand complementation mechanism appears to be
Table 3. Structurally Related Ligand Binding Regions from the A-Domains of Gram-Positive MSCRAMMs Share Conserved Motifs
MSCRAMM TYTFTDYVD motif Number of Latching
(Accession number) or its variant residuesa Sequenceb Methodc Organism
SdrG (AAF72510) TYTFTDYVD 207 SSGQGQG 1a S. epidermidis
SdrF (AAF72509) TYTFTNYVD 200 GSSTAQG 4 S. epidermidis
ClfA (CAA79304) IYTFTDYVN 207 GSGSGDG 2 S. aureus
ClfB (CAA12115) TFVFTDYVN 204 GGGSADG 1b S. aureus
SdrC (CAA06650) TYTFTNYVD 196 GSSTANG 4 S. aureus
SdrD (CAA06651) TYTFTDYVD 212 NQSGGAG 4 S. aureus
SdrE (CAA06652) TYTFTDYVD 216 GGGDGTV 3 S. aureus
Bbp (CAB75732) TYKFTDYVD 216 VVVTVSV 3 S. aureus
FnbpA (CAA65106) RYTFTNDIE 210 NKANGNE 3 S. aureus
FnbpB (CAA44726) RYTFKEYVQ 204 NNAQGDG 3 S. aureus
Cna (Q53654) TITFNDKVE 200 ANAGIEG 1b S. aureus
Ace (AAG23954) VFIYKDHVV 208 VEGEASG 1b E. faecalis
a Residues in between the TYTFTDYVD motif and the latching sequence.
b Alternate residues that are projected into the region between the two -sheets and face the TYTFTDYVD motif are shown in bold.
c Latching sequence identified method: (1a) Crystal structure-this work. (1b) Crystal structures of A-region of collagen binding MSCRAMMS
Ace, Cna and Fg- binding MSCRAMM ClfB (Champion Deivanayagam, Y.X., Timothy Foster, M.H., and S.V.L.N., unpublished data; K.P., Y.X.,
D.C., M.H., S.V.L.N., unpublished data; Yinong Zong, Y.X., M.H., and S.V.L.N., unpublished data). (2) Modeling the C-terminus of rClfA crystal
structure. (3) Homology modeling. (4) Pairwise sequence alignment.
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unique to fibronectin binding MSCRAMMs. The unor- M.H., and S.V.L.N., unpublished data), Ace (K.P., Y.X.,
D.C., M.H., and S.V.L.N., unpublished data), and Cnadered repeats are so far only found in the C-terminal
half of fibronectin binding MSCRAMMs and the N-ter- (Yinong Zong, Y.X., M.H., S.V.L.N., unpublished data).
All of these MSCRAMMs contain a cleft in one of the IgG-minal type I modules of fibronectin are, to this point, the
only ligand that accommodates the MSCRAMM unor- like folds that could accommodate a latching strand. A
survey of the available genomes of five pathogenicdered repeats.
The dock, lock, and latch model describes a bind- gram-positive bacteria revealed that all organisms en-
code putative cell wall anchored proteins predicted toing mechanism for the N-terminal A domains of the
MSCRAMMs. These domains are composed of two or contain repeated, in tandem IgG-like folded domains.
Furthermore, variants of the TYTFTDYVD motif, whichthree IgG-like folds and conserved among a large family
of related putative MSCRAMMs. In contrast to fibronec- appears to be associated with the latching cleft and
putative latching sequences are also present in sometin, the ligands that bind to the IgG-like A-domains are
linear short peptide sequences. This ligand group is of these cell wall anchored proteins from gram-positive
bacteria. We therefore propose that the dock, lock, andlarge (and growing) and includes fibrinogen, elastin, ker-




The structure of the S. epidermidis adhesin SdrG in Purification, Crystallization, and Data Collection
complex with a Fg-derived peptide presented here pro- The rSdrG(273–597) polypeptide was expressed in E. coli and purified
by immobilized metal chelate affinity chromatography, followed byvides the atomic details of the interactions between a
anion-exchange and gel-filtration chromatography, as previouslystaphylococcal MSCRAMM and its host ligand mole-
described (Davis et al., 2001). The rSdrG(273–597) protein was mixedcule. Analysis of the crystal structures of the SdrG(276–596)-
with excess peptide (Peptide: protein ratio of 1.5 or greater) andpeptide complex- and the apo-SdrG(276–596) allowed us to screened for crystallization conditions. Crystals were obtained by
propose the dock, lock, and latch mechanism presented hanging drop method using 50% PEG 2000 Mono Methyl Ether
in this report. (MME), 0.2 M NaCl and 50 mm buffer (Tris, HEPES, MES, Pipes,
Cacodylate) between pH 5.5–7.5. The crystals belong to the ortho-S. epidermidis is an opportunistic pathogen. A com-
rhombic P212121 space group and diffracted to 1.86 A˚. The crystals ofmon inhabitant of human skin and mucosal membranes,
apo-rSdrG(276–597) were obtained at similar conditions, and, however,S. epidermidis has emerged as a major nosocomial
belong to the triclinic P1 space group. The X-ray diffraction datapathogen associated with infected implanted medical
for both apo- and complex crystals were collected at 100 K using
devices (Huebner and Goldman, 1999) such as pace- in house X-ray source. DENZO/SCALEPACK package (Otwinowski
makers, mechanical heart valves, artificial joints, and and Minor, 1997) was used for diffraction data processing.
catheters (Costerton et al., 1999; Donlan, 2001). In bio-
Phase Determination, Model Building, and Refinementmaterial-centered infections, staphylococci colonize the
rSdrG(276–597)-Peptide Complexsurfaces of implanted biomaterials that are coated with
The rSdrG(276–597)-peptide complex was solved by multiple isomor-host proteins such as Fg. These surfaces are often ex-
phous replacement method using two derivatives such as Trimethyl
posed to constant fluid shear forces. Therefore, strong Lead acetate (TMLA) and platinum. SOLVE (Terwilliger and Berend-
interactions between the pathogen and the biomaterial zen, 1999) program was used for the refinement of heavy atom sites
and subsequent phase calculations. The initial solvent flattenedare essential for bacterial adhesion and colonization.
electron density map revealed excellent density allowing the con-The now proposed dock, lock, and latch model of SdrG
struction of a molecular model for both copies of the molecule inbinding to Fg provides the molecular basis for the forma-
the asymmetric unit. QUANTA (Molecular Simulations, Inc) was usedtion of a stable adhesin-ligand complex. This model
for tracing and model building and CNS (Brunger, 1998) for refine-
describes the structural changes that stabilize the over- ment. The refinements were monitored throughout using free R val-
all MSCRAMM-ligand complex, and would tightly secure ues and the model was refined to final R factor/Rfree of 0.209/0.221
using all reflections from 20 to 1.86 A˚. The side chain density forthe ligand in place under fluid shear forces. In addition,
few residues (in complex I: Lys320, Lys379, Asp474, Glu475, Lys544,the presented structure reveals how SdrG blocks the
Leu594, and Pro596 and in complex II: Lys379, Gln519, Lys549,thrombin cleavage site in Fg B chain, inhibiting the
Glu567, Tyr568, and Leu594) were not clear and they were modifiedrelease of fibrinopeptide B. It is possible that staphylo-
to alanines. Similarly, the peptide residue Phe9af in complex I and
cocci express proteins that bind to Fg to prevent the Arg17f in complex II were truncated to alanines due to lack of side
release of chemotactic elements such as fibrinopeptide chain density. Final refinement statistics are summarized in Table 1.
Apo-rSdrG(276–597)B, thus reducing the influx of phagocytic neutrophils
The structure of peptide free rSdrG(276–597) was solved by the molecu-to the infection site and enhancing the probability of
lar replacement method using Amore (Navaza, 1994), refined withbacterial survival in the host. Surprisingly, we found that
CNS and the model built with QUANTA. The crystal structure ofthe native Fg (6-20) sequence is not the optimal se-
rSdrG(276–597)-peptide complex (without the bound peptide) was usedquence for SdrG binding, suggesting that multiple li- as the starting model. The first round of refinement, using 20–3.5 A˚
gands could be accommodated in the MSCRAMM bind- resolution data reduced R factor to 0.287 and Rfree to 0.345. A few
cycles of further refinement and rebuilding lowered the R factoring region.
and Rfree to 0.250 and 0.319 respectively. A summary of refinementWe currently have positively identified the dock, lock,
statistics is presented in Table 1.and latch model only for the interaction of SdrG with
Fg. However, we have solved additional structures of
Synthetic Peptides
related ligand binding domains, such as those from ClfA The synthesis and purification procedures of the peptides were
(Deivanayagam et al., 2002), ClfB (Champion Deivanaya- described previously (Davis et al., 2001). For the following peptides
the amino acid residue numbers are given and the sequence follows:gam, Samuel Perkins, Evelyn Walsh, Timothy Foster,
Crystal Structure of MSCRAMM-Ligand Complex
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peptide 1-25, composed of first 25 residues of the N terminus of Homology Modeling
Homology modeling was carried out using the WHAT IF serverthe B chain of Fg (QGVNDNEEGFFSARGHRPLDKKREE); peptide
6-20 (NEEGFFSARGHRPLD); peptide 6-20(F3) (NEEGFFFSARG (http://www.cmbi.kun.nl/gv/servers/WIWWWI/). Initially, the pair-
wise sequence alignment of template and target sequences wasHRPLD); a scrambled version of peptide 1-25 (FSERKDLHQGEGN
PREFVENDAKGR). performed using the server Protein Information Resource (PIR)
(http://pir.georgetown.edu/pirwww/search/pairwise.html). The aligned
sequences, along with the template coordinate, were submitted toSurface Plasmon Resonance Spectroscopy
the WHAT IF server and the homology model were obtained. TheThe 1-25 Fg peptide was diluted in 10 mM formate [pH 3.5] and
insertions in the loop regions were modeled using the server CODAimmobilized on a CM5 sensorchip (BIAcore, Uppsala, Sweden). The
(http://www-cryst.bioc.cam.ac.uk/coda/). The short contacts sideimmobilization level was 430 RU. The recombinant proteins were
chain contacts were manually adjusted and the final model wasinjected on the peptide-coated surface at 25 l/min (in HBS, 10 mM
energy minimized using CNS (Brunger, 1998). The stereochemistryHEPES [pH 7.5], 150 mM NaCl, and 25C) and the binding and
of the model was evaluated with the program PROCHECK (Laskow-dissociation was registered in a BIAcore 3000 instrument. The re-
ski et al., 1993) and the residue environment was analyzed with thecombinant SdrG(273–597) was diluted to 50 g/ml in 10 mM Na Acetate
VERIFY_3D program (Luthy et al., 1992). Qualitative statistics of the[pH 4.0] and immobilized in a CM5 sensorchip. The immobilization
models are presented in Supplemental Table S1 available at http://level was 1560 RU. The synthetic peptides, diluted to 0.1 M in
www.cell.com/cgi/content/full/115/2/217/DC1.HBS, were injected on the rSdrG-coated surface at 150 l/min and
the binding and dissociation was registered in a BIAcore 3000 in-
Supplemental Datastrument.
Details of bacterial strains, polymerase chain reaction amplification
of the sdrG gene fragments, site-directed mutagenesis and purifica-Fluorescence Spectroscopy Assays
tion of recombinant proteins are provided in the Supplemental Data,The binding of rSdrG to immobilized Fg was analyzed in a solid
available at available at http://www.cell.com/cgi/content/full/115/2/phase assay as previously described (Davis et al., 2001). The binding
217/DC1.of rSdrG to fluorescein-labeled N-terminal  chain peptide analogs
was quantitated by fluorescence polarization, and this method,
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